Back to Search
SAMEER DESAI, MD
MD
Hematology & Oncology Physician
NPI: 1487776373IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
25MA08233000(NJ)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway.
PMID 16424026·Cancer Res·2006
8-other
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes.
PMID 12640119·Mol Cell Biol·2003
7-preclinical
Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.
PMID 11479235·Cancer Res·2001
7-preclinical
Ubiquitin, SUMO-1, and UCRP in camptothecin sensitivity and resistance.
PMID 11193908·Ann N Y Acad Sci·2000
7-preclinical
Thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents.
PMID 19652579·Am J Clin Oncol·2010
4-observational
Multiple cranial nerve enhancement: uncommon imaging finding in early infantile Krabbe's disease.
PMID 19021834·J Neuroimaging·2010
5-case
CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis.
PMID 19679608·Eur Respir J·2010
8-other
The treatment of pediatric Philadelphia positive (Ph+) leukemias in the imatinib era.
PMID 19621426·Pediatr Blood Cancer·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 VERONICA AVE, SUITE 201
SOMERSET, NJ 08873 - Phone
- (732) 246-4882
Quick Facts
- NPI
- 1487776373
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile